Early distribution of intravenously injected mesenchymal stem cells in rats with acute brain trauma evaluated by 99mTc-HMPAO labeling

Nuclear Medicine and Biology

Volumn 38, Issue 8, 2011, Pages 1175-1182

  Park, Bok Nam ^a   Shim, Wooyoung ^a,b   Lee, Gwang ^a,b   Bang, Oh Young ^c   An, Young Sil ^a   Yoon, Joon Kee ^a   Ahn, Young Hwan ^a  

^a Ajou University School of Medicine   (South Korea)

^b Ajou University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

99mTc HMPAO; Bone marrow mesenchymal stem cells; Cell tracking; Gamma camera; Gamma counter; Traumatic brain injury

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL LABELING; CELL MIGRATION; CONTROLLED STUDY; FEMALE; HEMISPHERE; IN VIVO STUDY; ISOTOPE LABELING; LIVER; LUNG; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; RAT; SCINTILLATION CAMERA; SPLEEN; TISSUE DISTRIBUTION; TRAUMATIC BRAIN INJURY;

ANIMALS; APOPTOSIS; BRAIN; BRAIN INJURIES; CASE-CONTROL STUDIES; FEMALE; FLUORESCENT DYES; GAMMA CAMERAS; LIVER; LUNG; MESENCHYMAL STEM CELLS; MICROSCOPY, POLARIZATION; NECROSIS; ORGANIC CHEMICALS; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; TECHNETIUM TC 99M EXAMETAZIME; TISSUE DISTRIBUTION;

EID: 82655162157     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.05.009     Document Type: Article

References (24)

1. Ballas C.B., Zielske S.P., Gerson S.L. Adult bone marrow stem cells for cell and gene therapies: implications for greater use. J Cell Biochem Suppl 2002, 38:20-28.
2. Bang O.Y., Lee J.S., Lee P.H., Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005, 57:874-882.
3. Friedenstein A.J., Deriglasova U.F., Kulagina N.N., Panasuk A.F., Rudakowa S.F., Luria E.A., et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974, 2:83-92.
4. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
5. Barbash I.M., Chouraqui P., Baron J., Feinberg M.S., Etzion S., Tessone A., et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003, 108:863-868.
6. 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med 2004, 45:512-518.
7. Cho Y.H., Kim H.S., Lee K.H., Lee Y.E., Chang J.W. The behavioral effect of human mesenchymal stem cell transplantation in cold brain injured rats. Acta Neurochir Suppl 2006, 99:125-132.
8. Frankel M.S. In search of stem cell policy. Science 2000, 287:1397.
9. Beeres S.L., Bengel F.M., Bartunek J., Atsma D.E., Hill J.M., Vanderheyden M., et al. Role of imaging in cardiac stem cell therapy. J Am Coll Cardiol 2007, 49:1137-1148.
10. Hill J.M., Dick A.J., Raman V.K., Thompson R.B., Yu Z.X., Hinds K.A., et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003, 108:1009-1014.
11. Kraitchman D.L., Heldman A.W., Atalar E., Amado L.C., Martin B.J., Pittenger M.F., et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003, 107:2290-2293.
12. Chen Z., Meng H., Xing G., Chen C., Zhao Y., Jia G., et al. Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett 2006, 163:109-120.
13. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113:823-839.
14. Bengel F.M., Schachinger V., Dimmeler S. Cell-based therapies and imaging in cardiology. Eur J Nucl Med Mol Imaging 2005, 32(Suppl 2):S404-S416.
15. Bindslev L., Haack-Sorensen M., Bisgaard K., Kragh L., Mortensen S., Hesse B., et al. Labelling of human mesenchymal stem cells with indium-111 for SPECT imaging: effect on cell proliferation and differentiation. Eur J Nucl Med Mol Imaging 2006, 33:1171-1177.
16. Stodilka R.Z., Blackwood K.J., Kong H., Prato F.S. A method for quantitative cell tracking using SPECT for the evaluation of myocardial stem cell therapy. Nucl Med Commun 2006, 27:807-813.
17. 111In-labeled bone marrow mesenchymal stem cells in acute brain trauma model. Nucl Med Biol 2010, 37:381-388.
18. Ellisen L.W., Carlesso N., Cheng T., Scadden D.T., Haber D.A. The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells. EMBO J 2001, 20:1897-1909.
19. Hellmann M.A., Panet H., Barhum Y., Melamed E., Offen D. Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci Lett 2006, 395:124-128.
20. 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med 2006, 47:1295-1301.
21. 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution. Cell Transplant 2009, 18:1369-1379.
22. Riggi N., Cironi L., Provero P., Suva M.L., Kaloulis K., Garcia-Echeverria C., et al. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res 2005, 65:11459-11468.
23. Fierro F.A., Sierralta W.D., Epunan M.J., Minguell J.J. Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination. Clin Exp Metastasis 2004, 21:313-319.
24. Zhu W., Xu W., Jiang R., Qian H., Chen M., Hu J., et al. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol 2006, 80:267-274.